These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 14715080

  • 1. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.
    Cinar B, Yeung F, Konaka H, Mayo MW, Freeman MR, Zhau HE, Chung LW.
    Biochem J; 2004 Apr 15; 379(Pt 2):421-31. PubMed ID: 14715080
    [Abstract] [Full Text] [Related]

  • 2. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF, Wang Y, Cho JY, Libermann TA.
    Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841
    [Abstract] [Full Text] [Related]

  • 3. Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha.
    Ko S, Shi L, Kim S, Song CS, Chatterjee B.
    Mol Endocrinol; 2008 Feb 01; 22(2):273-86. PubMed ID: 17975021
    [Abstract] [Full Text] [Related]

  • 4. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes.
    Gao N, Zhang J, Rao MA, Case TC, Mirosevich J, Wang Y, Jin R, Gupta A, Rennie PS, Matusik RJ.
    Mol Endocrinol; 2003 Aug 01; 17(8):1484-507. PubMed ID: 12750453
    [Abstract] [Full Text] [Related]

  • 5. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
    Cleutjens KB, van der Korput HA, van Eekelen CC, van Rooij HC, Faber PW, Trapman J.
    Mol Endocrinol; 1997 Feb 01; 11(2):148-61. PubMed ID: 9013762
    [Abstract] [Full Text] [Related]

  • 6. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H.
    Cancer Res; 1994 Oct 15; 54(20):5474-8. PubMed ID: 7522959
    [Abstract] [Full Text] [Related]

  • 7. Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells.
    Yeung F, Li X, Ellett J, Trapman J, Kao C, Chung LW.
    J Biol Chem; 2000 Dec 29; 275(52):40846-55. PubMed ID: 11006269
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
    Hisatake JI, Ikezoe T, Carey M, Holden S, Tomoyasu S, Koeffler HP.
    Cancer Res; 2000 Oct 01; 60(19):5494-8. PubMed ID: 11034093
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells.
    Wang LG, Liu XM, Kreis W, Budman DR.
    Cancer Res; 1997 Feb 15; 57(4):714-9. PubMed ID: 9044850
    [Abstract] [Full Text] [Related]

  • 12. Down regulation of PSA by C/EBPalpha is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell line.
    Yin H, Radomska HS, Tenen DG, Glass J.
    BMC Cancer; 2006 Jun 14; 6():158. PubMed ID: 16774685
    [Abstract] [Full Text] [Related]

  • 13. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.
    Ikezoe T, Chen SS, Yang Y, Heber D, Taguchi H, Koeffler HP.
    Int J Oncol; 2003 Nov 14; 23(5):1461-70. PubMed ID: 14532991
    [Abstract] [Full Text] [Related]

  • 14. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
    Sadar MD, Gleave ME.
    Cancer Res; 2000 Oct 15; 60(20):5825-31. PubMed ID: 11059779
    [Abstract] [Full Text] [Related]

  • 15. Nuclear factor-kappaB activates transcription of the androgen receptor gene in Sertoli cells isolated from testes of adult rats.
    Zhang L, Charron M, Wright WW, Chatterjee B, Song CS, Roy AK, Brown TR.
    Endocrinology; 2004 Feb 15; 145(2):781-9. PubMed ID: 14576180
    [Abstract] [Full Text] [Related]

  • 16. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
    Dai JL, Burnstein KL.
    Mol Endocrinol; 1996 Dec 15; 10(12):1582-94. PubMed ID: 8961268
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.